IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
ImageneBio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$4.00−0.04 (-0.99%)
Close on Oct 19, 2026
- Market cap
- $64.65M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
ImageneBio has not reported a dividend
No dividend per share appears in ImageneBio's annual filings since fiscal 2019.